feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Texans beat Titans with field

trending

Browns lead Ravens at half

trending

49ers beat sloppy Cardinals

trending

Jaguars affect AFC playoff picture

trending

NFL AFC Standings Updated

trending

Morgan Stanley raises Nvidia target

trending

Rockets beat Magic in OT

trending

Wells Fargo: Nvidia stock target

trending

Avalanche beat Islanders, 4-1

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Contaminated Baby Formula Hospitalizes Infants Nationwide

Contaminated Baby Formula Hospitalizes Infants Nationwide

10 Nov

•

Summary

  • At least 13 infants hospitalized after consuming contaminated ByHeart formula
  • Recall affects specific lots of powdered infant formula
  • Botulism can lead to flaccid paralysis and breathing problems
Contaminated Baby Formula Hospitalizes Infants Nationwide

On November 8, 2025, the US Food and Drug Administration (FDA) announced that illnesses linked to contaminated baby formula from specific lots of ByHeart Whole Nutrition Infant Formula had been reported in 10 US states. While there have been no reported deaths, the recall affects certain batches of the powdered formula.

Infant botulism is a rare but serious illness that occurs when babies under one year old consume food contaminated with spores from the Clostridium botulinum bacterium. If not treated quickly, the condition can lead to flaccid paralysis, which may cause breathing problems and require a long hospital stay. The FDA warns that botulism can be deadly, and parents should act immediately if they notice any signs or symptoms in their child after consuming the affected formula.

As a result of this incident, conversations about baby nutrition and feeding practices are likely to resurface. Parents may explore alternative feeding options or different brands to ensure they are using safe and healthy products for their infants.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The ByHeart Whole Nutrition Infant Formula recall was issued after at least 13 infants were hospitalized due to consumption of contaminated formula from specific lots. The formula has been linked to the rare but serious illness of infant botulism.
Infant botulism occurs when babies under one year old consume food contaminated with spores from the Clostridium botulinum bacterium. If not treated quickly, it can lead to flaccid paralysis, which may cause breathing problems and require a long hospital stay.
If your child has taken the affected ByHeart formula and shows signs of botulism, such as constipation, feeding problems, or muscle weakness, parents should seek medical help immediately. The CDC advises keeping a close eye on your child, as symptoms may not appear for weeks.

Read more news on

Healthside-arrow

You may also like

FDA Eases Biosimilar Approvals, but Patent Hurdles Remain

14 Nov • 11 reads

article image

UK Approves Leqembi for Early Alzheimer's Treatment

14 Nov • 18 reads

article image

FDA Clears BrainsWay's Deep TMS System for Adolescent Depression Treatment

14 Nov • 12 reads

article image

FDA Approves Rare Leukemia Pill Komzifti, Faces Boxed Warning

14 Nov • 15 reads

Biocon Cuts Biosimilar Costs by 50% as US Eases Testing Rules

13 Nov • 16 reads

article image